Robert Kraal

Co-Founder

2019 - Current

Chairman Of The Board

2019

Entrepreneur, Board Advisor, Investor

2018

Member Of The Board Of Advisors

2019

Chairman Of The Board

2020 - 2022

Board Member

2019 - 2021

COO

2016 - 2018

MyTomorrows is the online platform providing early access to the latest drug innovations. Drug development takes 10-15 years from innovation to registration. Promising drugs can show safety and effectiveness in patients after 6-7 years of development. Many patients and their doctors need access to innovative drugs today, and can't wait the extra years it takes for a drug to receive official marketing approval. We help them.

EVP global acquiring and Processing Adyen

2011 - 2016

End-responsible for creating and executing the Global acquiring and processing proposition for Adyen, including own licenses and BIN sponsorships for all card schemes on 5 continents.

COO

2010 - 2014

Director Business Development

2009 - 2010

Operations Director

2008 - 2010

Industry Manager Retail, Education, Entertainment

2007 - 2008